Abstract Background The United States (US) Food & Drug Administration (FDA) recently
approved a human papillomavirus (HPV) vaccine with the purpose of reducing the risk of …

Background: Human papillomavirus (HPV) is the major risk factor for cervical cancer.
Methods: We implemented a retrospective case-series study to discern HPV knowledge …

Human papillomavirus (HPV) infection is a central and necessary, although not sufficient,
cause of cervical cancer. Besides HPV, the additional multiple risk factors related with the …

Aims and objectives To enhance understanding of young women's experiences of human
papillomavirus‐related cervical cancer prevention in T aiwan. Background High‐risk types of …

This report addresses several areas including the progress made toward global
implementation of currently licensed human papillomavirus (HPV) vaccines, and monitoring …

Skip the header click to show the menu Menu Cart Login Login/Register Institutional Access
Access Options Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Advanced …

Human papillomavirus (HPV) infection is the most frequent viral sexually transmitted
infection in the world. HPV is currently the most prevalent infection responsible for female …

Background a vast body of evidence has emerged, in the recent decades, indicating the
persistence of high-risk Human Papillomavirus (HPV) infection as the necessary cause …

A wealth of evidence has led to the conclusion that virtually all cases of cervical cancer are
attributable to persistent infection by a subset of human papillomavirus (HPV) types …

Persistent infections with high-risk Human papillomavirus (HPV) can lead to cervical cancer.
This fact could imply that vaccination against HPV could prevent this disease. Such vaccines …